Setting up an 'EPO' system. Management of patients receiving recombinant human erythropoietin
Brown, S.M.
Professional Nurse 7(5): 282-283; 286-287
1992
ISSN/ISBN: 0266-8130 PMID: 1738775 Document Number: 405169
As more people with end stage renal disease are treated with erythropoietin for their anaemia, a well-coordinated system is essential to monitor their response to treatment. This is best achieved by keeping management of the system in the hands of one or two people.
Document emailed within 1 workday
Related Documents
Laupacis, A. 1991: A randomized double-blind study of recombinant human erythropoietin in anaemic hemodialysis patients. Canadian Erythropoietin Study Group Transplantation Proceedings 23(2): 1825-1826Bargman, J. 1989: Recombinant human erythropoietin in patients on peritoneal dialysis Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 9(4): 245-246
Urra, J.M.; de la Torre, M.; Alcazar, R.; Peces, R. 1997: Rapid method for detection of anti-recombinant human erythropoietin antibodies as a new form of erythropoietin resistance Clinical Chemistry 43(5): 848-849
Virón, B.éa.; Kolta, A.; Kiladjian, J.J.; Mignon, F.; Mayeux, P.; Casadevall, N. 2002: Antibodies against human recombinant erythropoietin: an unusual cause of erythropoietin resistance Nephrologie 23(1): 19-22
Mohini, R. 1989: Clinical efficacy of recombinant human erythropoietin in hemodialysis patients Seminars in Nephrology 9(1 Suppl 1: 16-21
Abels, R.I. 1992: Use of recombinant human erythropoietin in the treatment of anemia in patients who have cancer Seminars in Oncology 19(3 Suppl 8: 29-35
Kakuk, G.; Kárpáti, I.; Mátyus, J. 1990: Recombinant human erythropoietin in the therapy of anemia in hemodialyzed patients Orvosi Hetilap 131(43): 2365-2366; 2369-2371
Ramello, A.; Malcangi, U.; Bruno, M.; Perosa, P.; Reina, E.; Rizzuto, A.; Nasini, M.G.; Carozzi, S. 1990: Treatment of anaemia in CAPD patients with recombinant human erythropoietin Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 6: 308-311
Moynot, A.; Zins, B.; Naret, C.; Canaud, B.; Polito, C.; Judith, D.; Poisson, D.; Cavalli, I.; Jacquot, C.; Drüeke, T. 1990: One-year treatment of 43 chronic hemodialysis patients with recombinant human erythropoietin Presse Medicale 19(3): 111-115
Henry, D.H. 1993: Recombinant human erythropoietin for the treatment of anemia in patients with advanced cancer Seminars in Hematology 30(4 Suppl 6: 12-16
Jacquot, C.; Berthelot, J.M.; Chiappini-Judith, D.; Ferragu-Haguet, M.; Lefebvre, A.; Masselot, J.P.; Moynot, A.; Frydman, M.O.; Peterlongo, F. 1990: Treatment of anemia in chronic hemodialysis patients with recombinant human erythropoietin: long-term results in 15 patients Nephrologie 11(1): 11-16
Boratyńska, M.; Szewczyk, Z.; Szepietowski, T.; Czyz, W.; Cybulski, K.; Bogucki, J.; Szczepański, J. 1990: Human recombinant erythropoietin in the treatment of anemia in patients on long-term hemodialysis Przeglad Lekarski 47(11): 741-745
Melappioni, M.; Giansanti, R.; Boemi, M.; Baldassari, M.; Baldini, S.; Pierangeli, T.; Radicioni, R.; Fumelli, P.; Panichi, N. 1992: Hemo-rheologic changes following treatment with human recombinant erythropoietin in chronic hemodialysis patients Minerva Urologica e Nefrologica 44(2): 155-159
Boratyńska, M.; Magott, M.; Szewczyk, Z. 1996: Treatment with human recombinant erythropoietin and nutritional status of patients on lon term dialysis Przeglad Lekarski 53(5): 402-405
Zelichowski, G.; Olszowska, A.; Lubas, A.; Wańkowicz, Z. 2002: Influence of parathormone level on the doses of human recombinant erythropoietin in haemodialysed patients Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 13(77): 373-375
Corwin, H.L.; Gettinger, A.; Pearl, R.G.; Fink, M.P.; Levy, M.M.; Shapiro, M.J.; Corwin, M.J.; Colton, T. 2002: Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial JAMA 288(22): 2827-2835
Bösze, P.; Mayer, A.; Thurzó, L.; Kiss, A.; Rák, K.; Stumpf, J. 1995: Recombinant human erythropoietin in the treatment of anemic patients undergoing chemotherapy for cancer Orvosi Hetilap 136(47): 2567-2572
Trakarnvanich, T.; Thitiarcharkul, S. 2004: Comparison between intravenous recombinant human erythropoietin and subcutaneous injection in Thai hemodialysis patients Journal of the Medical Association of Thailand 87(9): 1041-1047
Acharya, V.N.; Sinha, D.K.; Almeida, A.F.; Pathare, A.V. 1995: Effect of low dose recombinant human omega erythropoietin (rHuEPO) on anaemia in patients on hemodialysis Journal of the Association of Physicians of India 43(8): 539-542
Zehnder, C.; Blumberg, A. 1989: Human recombinant erythropoietin treatment in transfusion dependent anemic patients on maintenance hemodialysis Clinical Nephrology 31(2): 55-59